Thought Leadership
 
Email Page
Stem Cell Companies Beware: FDA May Come Knocking
January 28, 2019
Chad Landmon and Jonathan Knowles
Bloomberg BNA Insights

Axinn partner Chad Landmon and associate Jonathan Knowles authored the Bloomberg BNA Insights article, "Stem Cell Companies Beware: FDA May Come Knocking."

Click here to access the article. Reproduced with permission from Copyright 2019 The Bureau of National Affairs, Inc. (800-372-1033) www.bna.com.